当前位置:Public Access >页面
Chinese/English
The study of Ruxolitinib as a front-line Therapy for pediatric Hemophagocytic Lymphohistiocytosis
Filter Options
Patient No. Patient Name Patient Gender
Sitting Education Date of enrollment FromTo
       More Options
Patient No Gender Date of enrollment Sitting Creater Operate
NO participants recorded。